Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 33733 | 86 | 41.6 | 89% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 222 | 19941 | LYMPHANGIOGENESIS//ANGIOGENESIS//ENDOSTATIN |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | ACUTE REJECTION REACTION | Author keyword | 2 | 67% | 2% | 2 |
| 2 | TUMOR ANGIOGENESIS | Address | 1 | 25% | 3% | 3 |
| 3 | E S 8 | Address | 1 | 33% | 2% | 2 |
| 4 | ANGIOGENESIS VUMC CANC AMSTERDAM | Address | 1 | 50% | 1% | 1 |
| 5 | ANGIOGENSIS | Address | 1 | 50% | 1% | 1 |
| 6 | ENDOCARDIUM PATHOLOGY | Author keyword | 1 | 50% | 1% | 1 |
| 7 | INVEST BIOMED AGUST PI I SUNYER | Address | 1 | 50% | 1% | 1 |
| 8 | SS 2 INTEGRINS | Author keyword | 1 | 50% | 1% | 1 |
| 9 | TIME LAPSE INTRAVITAL MICROSCOPY | Author keyword | 1 | 50% | 1% | 1 |
| 10 | TUMOUR BEARING | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | TUMOR MICROVESSELS | 2 | 67% | 2% | 2 |
| 2 | ENDOTHELIAL CELL ANERGY | 1 | 50% | 2% | 2 |
| 3 | GLIOBLASTOMA VESSELS | 1 | 50% | 1% | 1 |
| 4 | ICAM 1 GENE EXPRESSION | 1 | 50% | 1% | 1 |
| 5 | BLOOD MONOCYTE MIGRATION | 0 | 33% | 1% | 1 |
| 6 | CRANIAL WINDOWS | 0 | 20% | 1% | 1 |
| 7 | IP 10 GENE | 0 | 17% | 1% | 1 |
| 8 | ANGIOGENESIS FACTORS | 0 | 14% | 1% | 1 |
| 9 | CAPILLARY ARCHITECTURE | 0 | 13% | 1% | 1 |
| 10 | QUANTITATIVE ANGIOGENESIS | 0 | 13% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Angiogenesis modulates the tumour immune response | 1998 | 16 | 39 | 23% |
| Angiogenesis, a target for tumor therapy | 1998 | 18 | 39 | 21% |
| Tumor blood vessels, a difficult hurdle for infiltrating leukocytes | 2007 | 9 | 223 | 9% |
| Phenotype of the tumor vasculature; cell adhesion as a target for tumor therapy | 1997 | 9 | 49 | 12% |
| Biomarkers for novel targeted therapies of hepatocellular carcinoma | 2009 | 0 | 101 | 1% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | TUMOR ANGIOGENESIS | 1 | 25% | 3.5% | 3 |
| 2 | E S 8 | 1 | 33% | 2.3% | 2 |
| 3 | ANGIOGENESIS VUMC CANC AMSTERDAM | 1 | 50% | 1.2% | 1 |
| 4 | ANGIOGENSIS | 1 | 50% | 1.2% | 1 |
| 5 | INVEST BIOMED AGUST PI I SUNYER | 1 | 50% | 1.2% | 1 |
| 6 | GASTROENTEROL MALALTIES DIGEST | 0 | 33% | 1.2% | 1 |
| 7 | AFFILIATED NINGBO HOSP 2 | 0 | 17% | 1.2% | 1 |
| 8 | AFFILIATED YINZHOU HOSP | 0 | 17% | 1.2% | 1 |
| 9 | NEUROPATHOL PRION ZNP | 0 | 14% | 1.2% | 1 |
| 10 | RAYMOND BEVERLY SACKLER FDN CARDIOVASC | 0 | 14% | 1.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000163141 | INTERSTITIAL FLUID PRESSURE//EDWIN L STEELE//CANCER DETECTION AND TREATMENT |
| 2 | 0.0000137285 | ANTIANGIOGENIC CANCER VACCINE//CELL PROTEOMIC FOOTPRINTING//HER1 VACCINE |
| 3 | 0.0000135707 | SOLUBLE ICAM 1//SICAM 1//SOLUBLE INTERCELLULAR ADHESION MOLECULE 1 |
| 4 | 0.0000133186 | FLT1 PEPTIDE//ANTI FLT1 PEPTIDE//RETINYL |
| 5 | 0.0000123763 | MED CLIN 9//SECT RECONSTRUCT PLAST SURG//BIOMED ENGN IMAGING |
| 6 | 0.0000113077 | FLT 1//VEGF RECEPTORS//VEGF165B |
| 7 | 0.0000105315 | VASCULOGENIC MIMICRY//TIANJIN CANC HOSP//TEM7 |
| 8 | 0.0000103837 | PECAM 1//JAM A//JUNCTIONAL ADHESION MOLECULE A |
| 9 | 0.0000088077 | GICERIN//CD146//NEURITE OUTGROWTH FACTOR |
| 10 | 0.0000085213 | SELECTIN//L SELECTIN//SIALYL LEWIS X |